Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
- 24 June 2010
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 31 (8) , 381-390
- https://doi.org/10.1016/j.tips.2010.05.004
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- SZGR: a comprehensive schizophrenia gene resourceMolecular Psychiatry, 2010
- Animal models of gene–environment interactions in schizophreniaBehavioural Brain Research, 2009
- Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disordersTrends in Genetics, 2009
- Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1–ErbB4 and DISC1Published by Elsevier ,2009
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin SignalingCell, 2009
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophreniaTrends in Pharmacological Sciences, 2009
- The role of GSK‐3 in synaptic plasticityBritish Journal of Pharmacology, 2008
- AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia FamiliesBiological Psychiatry, 2008
- Evidence of Missense Mutations on the Neuregulin 1 Gene Affecting Function of Prepulse InhibitionBiological Psychiatry, 2008
- Cholinergic Circuits and Signaling in the Pathophysiology of SchizophreniaPublished by Elsevier ,2007